A pharmacokinetics of SAR442720 tablet vs capsule formulation (reference) when dosed in combination with pembrolizumab in participants with advanced solid tumors.
Latest Information Update: 21 Jan 2025
Price :
$35 *
At a glance
- Drugs Pembrolizumab (Primary) ; Vociprotafib (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- 21 Jan 2025 New trial record